In this episode of “The Tim Ferriss Show,” Tim interviews Dr. Nora Volkow, the director of the National Institute on Drug Abuse (NIDA). Dr. Volkow is a renowned scientist who has made significant contributions to the field of addiction research. She shares her fascinating life story, her groundbreaking work on drug addiction and brain imaging, and her insights into the current addiction crisis in the United States. This episode provides valuable information on addiction, the potential of psychedelic drugs for treatment, and the future of addiction research and treatment.
Dr. Nora Volkov is a renowned scientist and the director of the National Institute on Drug Abuse (NIDA). Her work has been instrumental in demonstrating that drug addiction is a brain disorder. She has pioneered the use of brain imaging to investigate how substance use affects brain functions, particularly the dopamine system and its impact on reward and self-control in addiction. Dr. Volkov’s research extends beyond addiction, making important contributions to the neurobiology of obesity, ADHD, and aging. Her life story is fascinating, with her early interest in science and her upbringing in a family with a unique background. She is driven by a desire to help the most vulnerable and is intolerant of injustices.
The addiction and overdose crises in the US are severe and difficult to control. They started with the over-prescription of opioid medications, leading to addiction and the rise of heroin use. The introduction of fentanyl in 2016 has made the crisis even more dangerous, as it is highly addictive and easy to smuggle. Fentanyl is now being mixed with other drugs, making it difficult to control and increasing the number of people overdosing. Dr. Volkov highlights the need to address addiction as a public health issue rather than relying on the failed war on drugs, which perpetuated structural racism and did not effectively reduce drug use or negative consequences to society.
Psychedelic drugs are being researched as potential treatments for mental illnesses and addiction. Silocycling, in particular, has shown promising results for depression and terminal illness patients. There is also potential for treating PTSD and substance use disorders. Dr. Volkov emphasizes the need for more research to understand the optimal doses, potential side effects, and administration methods of psychedelic drugs. While the data is still limited and preliminary, the potential benefits of psychedelic drugs in treating addiction and mental illnesses are promising and warrant further exploration.
Dr. Nora Volkov’s work on addiction research and her insights into the current addiction crisis provide valuable information on understanding addiction as a brain disorder and the need for effective treatment strategies. The potential of psychedelic drugs in treating mental illnesses and addiction offers hope for innovative and transformative approaches to treatment. However, more research is needed to fully understand their benefits, optimal dosing, and potential side effects. The interview with Dr. Volkov sheds light on the importance of addressing addiction as a public health issue and the need for equitable access to treatment. Overall, this episode offers valuable insights into addiction, neuroscience, and the future of addiction research and treatment.